仠	亂2榞儚僋亃CDDP+CPT-11 1, 8, 15
仠	亂2榞亃CBDCA+ETP1丆2丆3
仠	AMR丂1丆2丆3
仠	SCLC-Atezo堐帩椕朄
仠	CBDCA+ETP1丆2丆3
仠	SCLC-durvalumab-CBDCA-ETP
仠	NGT
仠	SCLC-maintenance-Durvalumab
丂	丂
丂	丂
丂	丂
丂	丂
丂	丂
丂	丂
丂	丂
丂	丂
丂	丂
丂	丂